[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355301-105":59,"doc-detail-355301-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tumour-immune-contexture-and-immune-evasion-in-sporadic-and-lynch-syndrome-associated-microsatellite-unstable-colorectal-cancers","Tumour immune contexture and immune evasion in sporadic and Lynch syndrome-associated microsatellite unstable colorectal cancers","","Microsatellite unstable colorectal cancers (MSI CRCs) carry high mutational burdens that generate immunogenicity, yet immunotherapy responses differ across patients. This study characterises immune-cell infiltration and mechanisms of immune evasion in MSI CRCs, links these patterns to clinical and genomic variables, and compares Lynch syndrome-associated (LS) tumors with sporadic MSI CRCs. Immunohistochemistry and whole-genome/RNA sequencing quantify T-cell and myeloid subsets, checkpoint signals, neoantigens, clonality, antigen presentation, and molecular subtypes. Results show distinct immune landscapes and immune evasion features between LS and sporadic tumors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumour-immune-contexture-and-immune-evasion-in-sporadic-and-lynch-syndrome-associated-microsatellite-unstable-colorectal-cancers/355301/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumour-immune-contexture-and-immune-evasion-in-sporadic-and-lynch-syndrome-associated-microsatellite-unstable-colorectal-cancers/355301.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What biological differences are explored between Lynch syndrome and sporadic MSI colorectal cancers?","Question",{"text":113,"@type":114},"The work compares immune cell infiltration patterns and immune evasion features between Lynch syndrome-associated and sporadic MSI CRCs, focusing on T-cell and myeloid landscapes as well as immune checkpoint-related changes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were immune cells and immune evasion mechanisms measured in the study?",{"text":118,"@type":114},"T-cell and myeloid subsets were assessed by immunohistochemistry. Whole-genome and RNA sequencing were used to evaluate somatic variants, tumour clonality, neoantigen burden, antigen presentation, immune checkpoint expression, and consensus molecular subtypes.",{"name":120,"@type":111,"acceptedAnswer":121},"What immune evasion-related signals differed between sporadic and Lynch syndrome MSI tumors?",{"text":122,"@type":114},"Lynch syndrome tumors showed higher immune cell scores and T-cell infiltration. In contrast, sporadic tumors displayed increased infiltration of protumorigenic M2-like macrophages and higher expression of immune checkpoints PDCD1LG2 and CD40LG.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355301,1790462864,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","British Journal of Cancer [www.nature.com/bjc](www.nature.com/bjc)  \nARTICLE OPEN   \nCellular and Molecular Biology  \nTumour immune contexture and immune evasion in sporadic and Lynch syndrome-associated microsatellite unstable colorectal cancers  \nSamantha Martin 1,2, Hanna Elomaa3, Juha P. Väyrynen 4, Maarit Ahtiainen5, Erkki-Ville Wirta 6,7, Jan Böhm8, Toni T. Seppälä2,6,7,9,10, Ari Ristimäki2,11, Kyösti Tahkola12, Anne Mattila12, Selja Koskensalo 13, Laura Renkonen-Sinisalo2,9, Anna Lepistö2,9, Jukka-Pekka Mecklin14,15, Kimmo Palin 1,2,10, Kristiina Rajamäki1,2 and Lauri A. Aaltonen 1,2,10 ✉  \n© The Author(s) 2026  \n\n|  | BACKGROUND: The high mutational burden in microsatellite unstable colorectal cancers (MSI CRCs) results in high immunogenicity, yet response rates to immunotherapy vary, suggesting underlying heterogeneity of the tumour immune landscape. Here, our aims were (1) to characterise the immune cell inﬁltrate and immune evasion in MSI CRCs,(2) to correlate these with clinical and genomic features, and (3) to compare these between Lynch syndrome (LS) and sporadic MSI CRCs.\u003Cbr>METHOD: Immunohistochemistry was utilised to detect T cell and myeloid cell subsets. Whole-genome and RNA sequencing were utilised to analyse somatic variants, tumour clonality, neoantigen burden, antigen presentation, immune checkpoint expression, and consensus molecular subtypes.\u003Cbr>RESULTS: Our results revealed higher immune cell scores in LS tumours, depicting higher T cell inﬁltration, compared to sporadic tumours. Conversely, sporadic tumours displayed increased inﬁltration of protumorigenic M2-like macrophages and increased expression of immune checkpoints PDCD1LG2 and CD40LG. Across our MSI CRC cohort, high neoantigen burden was associated with low tumour clonality.\u003Cbr>CONCLUSIONS: Our ﬁndings reveal differences between sporadic MSI and LS tumours in T cell and myeloid immune cell landscapes, and in immune evasion These differences may contribute to the variable immunotherapy responses among MSI CRC |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| .\u003Cbr>patients and are targetable by emerging therapeutic approaches. |  |  |\n|  | British Journal of Cancer (2026) 134:1019–1030; [https://doi.org/10.1038/s41416-025-03302-z](https://doi.org/10.1038/s41416-025-03302-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nMicrosatellite unstable colorectal cancer (MSI CRC) is a hypermutated subgroup of CRC characterised by a defective mismatch repair (MMR) system caused by pathogenic alterations in MMR genes MLH1, MSH2, MSH6 or PMS2 . Approximately 15% of CRCs are MMR-defective, of which approximately 20% are associated with a hereditary cancer syndrome, Lynch Syndrome (LS), while the remaining are sporadic [1] . LS patients inherit a heterozygous germline mutation in an MMR gene, and somatic inactivation of the second allele is required for tumorigenesis. In contrast, bi-  \nallelic hypermethylation of the MLH1 promoter with consequent downregulation of gene expression is most commonly responsible for MMR impairment in sporadic MSI CRC.  \nThe hypermutated nature of MSI CRC results in an abundance of neoantigens derived from frameshift peptides [2–6] . These arepresented on the tumour cell surface as part of HLA class I and class II complexes [7, 8] . Thus, T cells can recognise and target MSI tumour cells, resulting in high immunogenicity and a strong immune response. MSI CRCs are known to have greater T cell inﬁltration than non-hypermutated microsatellite stable (MSS)  \n1Medicum/Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland. 2Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland. 3Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland. 4Translational Medicine Research Unit, University of Oulu, Medical Research Center Oulu, and Oulu Uni","cbCaivTXCYcgPYpf","https://ap.wps.com/l/cbCaivTXCYcgPYpf","pdf",1431496,"English","# Background\n# Method\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What biological differences are explored between Lynch syndrome and sporadic MSI colorectal cancers?\",\"answer\":\"The work compares immune cell infiltration patterns and immune evasion features between Lynch syndrome-associated and sporadic MSI CRCs, focusing on T-cell and myeloid landscapes as well as immune checkpoint-related changes.\"},{\"question\":\"How were immune cells and immune evasion mechanisms measured in the study?\",\"answer\":\"T-cell and myeloid subsets were assessed by immunohistochemistry. Whole-genome and RNA sequencing were used to evaluate somatic variants, tumour clonality, neoantigen burden, antigen presentation, immune checkpoint expression, and consensus molecular subtypes.\"},{\"question\":\"What immune evasion-related signals differed between sporadic and Lynch syndrome MSI tumors?\",\"answer\":\"Lynch syndrome tumors showed higher immune cell scores and T-cell infiltration. In contrast, sporadic tumors displayed increased infiltration of protumorigenic M2-like macrophages and higher expression of immune checkpoints PDCD1LG2 and CD40LG.\"}]","Tumour immune contexture and immune evasion in sporadic and Lynch syndrome-associated microsatellite unstable colorectal cancers | PDF",1790117573,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa91867d6f1f23bc4928c610e06d1e65.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3455e910bca00eabb48f2465ebcc1725.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92f30bec00cb95d4d78e321546931e77.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d63e237e5e1671248a493689485a6f3.webp",980,1301]